Skip to main content
Log in

Immunology and cartilage regeneration

  • IMMUNOREGULATION/INFLAMMATION
  • Published:
Immunologic Research Aims and scope Submit manuscript

Abstract

The intrinsic regenerative capacity of avascular cartilage is limited. Cartilage injuries result in chronic, non-healing lesions requiring surgical management. Frequently, these surgical techniques make use of allogeneic cells and tissues. This review discusses the immune status of these materials. Cartilage allografts, often used in orthopedic and plastic surgeries, have rarely provoked a significant immune response. In whole cartilage transplants, the dense matrix produced by chondrocytes inhibits lymphocyte migration, preventing immune detection rendering them “antigen sequestered.” It is unclear whether isolated chondrocytes are immune-privileged; chondrocytes express immune inhibitory B7 molecules, indicating that they have some ability to modulate immune reactions. Allogeneic cartilage grafts often involve a bony portion often retaining immunogenic cells and proteins—to facilitate good surgical attachment and concern that this may enhance inflammation and immune rejection. However, studies of failed cartilage grafts have not found immune responses to be a contributing factor. Meniscus allografts, which also retain a bony portion, raise similar concerns as cartilage allografts. Despite this, the plugs improved patient outcomes, indicating that the immunological effects were not clinically significant. Finally, allogeneic mesenchymal stromal cells (MSCs) also are being investigated as a treatment for cartilage damage. MSCs have been demonstrated to have unique immunomodulatory properties including their ability to reduce immune cell infiltration and to modulate inflammation. In summary, the immunogenic properties of cartilage vary with the type of allograft used: Cartilage allografts demonstrate active immune-suppressive mechanisms as evidenced by lack of allograft rejection, while MSC allografts appear to be safe for transplantation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Freeman MAR. Adult articular cartilage. New York: Grune and Stratton; 1972.

    Google Scholar 

  2. Buckwalter JA, Einhorn TA, Simon SR. Orthopedic Basic Science, vol 471. Rosemont: American Academy of Orthopedic Surgeons; 2000.

  3. Sokoloff L. The joints and synovial fluid. New York: Academic press; 1978.

    Google Scholar 

  4. Huey DJ, Sanchez-Adams J, Willard VP, Athanasiou KA. Immunogenicity of bovine and leporine articular chondrocytes and meniscus cells. Tissue Eng Part A. 2012;18(5–6):568–75.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  5. Langer F, Gross AE. Immunogenicity of allograft articular cartilage. J Bone Joint Surg Am. 1974;56(2):297–304.

    CAS  PubMed  Google Scholar 

  6. Niemietz T, Zass G, Hagmann S, Diederichs S, Gotterbarm T, Richter W. Xenogeneic transplantation of articular chondrocytes into full-thickness articular cartilage defects in minipigs: fate of cells and the role of macrophages. Cell Tissue Res. 2014;358(3):749–61.

    Article  CAS  PubMed  Google Scholar 

  7. Gillies H. Technic in the construction of an auricle. Trans Am Acad Ophthamol Otolaryngol. 1942;46:119–21.

    Google Scholar 

  8. Chesterman PJ, Smith AU. Homotransplantation of articular cartilage and isolated chondrocytes. An experimental study in rabbits. J Bone Joint Surg Br. 1968;50(1):184–97.

    CAS  PubMed  Google Scholar 

  9. Adkisson HD, Milliman C, Zhang X, Mauch K, Maziarz RT, Streeter PR. Immune evasion by neocartilage-derived chondrocytes: implications for biologic repair of joint articular cartilage. Stem Cell Res. 2010;4(1):57–68.

    Article  CAS  PubMed  Google Scholar 

  10. Bugbee W, Cavallo M, Giannini S. Osteochondral allograft transplantation in the knee. J Knee Surg. 2012;25(2):109–16.

    Article  PubMed  Google Scholar 

  11. Chui K, Jeys L, Snow M. Knee salvage procedures: the indications, techniques and outcomes of large osteochondral allografts. World J Orthop. 2015;6(3):340–50.

    Article  PubMed Central  PubMed  Google Scholar 

  12. Oakeshott RD, Farine I, Pritzker KP, Langer F, Gross AE. A clinical and histologic analysis of failed fresh osteochondral allografts. Clin Orthop Relat Res. 1988;233:283–94.

    PubMed  Google Scholar 

  13. Gross AE, Shasha N, Aubin P. Long-term followup of the use of fresh osteochondral allografts for posttraumatic knee defects. Clin Orthop Relat Res. 2005;435:79–87.

    Article  PubMed  Google Scholar 

  14. El-Rashidy H, Villacis D, Omar I, Kelikian AS. Fresh osteochondral allograft for the treatment of cartilage defects of the talus: a retrospective review. J Bone Joint Surg Am. 2011;93(17):1634–40.

    Article  PubMed  Google Scholar 

  15. Sirlin CB, Brossmann J, Boutin RD, Pathria MN, Convery FR, Bugbee W, Deutsch R, Lebeck LK, Resnick D. Shell osteochondral allografts of the knee: comparison of mr imaging findings and immunologic responses. Radiology. 2001;219(1):35–43.

    Article  CAS  PubMed  Google Scholar 

  16. Hunt HE, Sadr K, Deyoung AJ, Gortz S, Bugbee WD. The role of immunologic response in fresh osteochondral allografting of the knee. Am J Sports Med. 2014;42(4):886–91.

    Article  PubMed  Google Scholar 

  17. Hamlet W, Liu SH, Yang R. Destruction of a cyropreserved meniscal allograft: a case for acute rejection. Arthroscopy. 1997;13(4):517–21.

    Article  CAS  PubMed  Google Scholar 

  18. Graf KW, Sekiya JK, Wojtys EM. Long-term results after combined medial meniscal allograft transplantation and anterior cruciate ligament reconstruction: minimum 8.5-year follow-up study. Arthroscopy. 2004;20(2):129–40.

    Article  PubMed  Google Scholar 

  19. Rijk PC. Meniscal allograft transplantation—part I: background, results, graft selection and preservation, and surgical considerations. Arthroscopy. 2004;20(7):728–43.

    Article  PubMed  Google Scholar 

  20. Elattar M, Dhollander A, Verdonk R, Almqvist KF, Verdonk P. Twenty-six years of meniscal allograft transplantation: is it still experimental? A meta-analysis of 44 trials. Knee Surg Sports Traumatol Arthrosc. 2011;19(2):147–57.

    Article  PubMed  Google Scholar 

  21. Yanke AB, Chalmers PN, Frank RM, Friel NA, Karas V, Cole BJ. Clinical outcomes of revision meniscal allograft transplantation: minimum 2-year follow-up. Arthroscopy. 2014;30(12):1602–8.

    Article  PubMed  Google Scholar 

  22. Ankrum JA, Ong JF, Karp JM. Mesenchymal stem cells: immune evasive, not immune privileged. Nat Biotechnol. 2014;32(3):252–60.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  23. Wu T, Liu Y, Wang B, Li G. The roles of mesenchymal stem cells in tissue repair and disease modification. Curr Stem Cell Res Ther. 2014;9(5):424–31.

    Article  CAS  PubMed  Google Scholar 

  24. Aggaral S, Pittenger MF. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood. 2005;105(4):1815–22.

    Article  Google Scholar 

  25. Maccario R, Podestà M, Moretta A, Cometa A, Comoli P, Montagna D, Daudt L, Ibatici A, Piaggio G, Pozzi S, Frassoni F, Locatelli F. Interaction of human Mesenchymal stem cells with cells involved in alloantigen-specific immune response favors the differentiation of CD4+ T-cell substes expressing a regulatory/suppressive phenotype. Haematologica. 2005;90(4):516–25.

    CAS  PubMed  Google Scholar 

  26. Uccelli A, Moretta L, Pistoia V. Mesenchymal stem cells in health and disease. Nat Rev Immunol. 2008;8(9):726–36.

    Article  CAS  PubMed  Google Scholar 

  27. Lombardo E, Van der Poll T, Delarosa O, Dalemans W. Mesenchymal stem cells as a therapeutic tool to treat sepsis. World J Stem Cells. 2015;7(2):368–79.

    Article  PubMed Central  PubMed  Google Scholar 

  28. Mason C, Dunnill P. Assessing the value of autologous and allogeneic cells for regenerative medicine. Regen Med. 2009;4(6):835–53.

    Article  PubMed  Google Scholar 

  29. Kristjánsson B, Honsawek S. Current perspectives in mesenchymal stem cell therapies for osteoarthritis. Stem Cells Int. 2014;2014:194318.

    Article  PubMed Central  PubMed  Google Scholar 

  30. Smith BD, Grande DA. The current state of scaffolds for musculoskeletal regenerative applications. Nat Rev Rheumatol. 2015;11(4):213–22.

    Article  CAS  PubMed  Google Scholar 

  31. Vangsness CT, Farr J, Boyd J, Dellaero DT, Mills CR, Leroux-williams M. Adult human mesenchymal stem cells delivered via intra-articular injection to the knee following partial medial meniscectomy: a randomized, double-blind, controlled study. J Bone Joint Surg Am. 2014;96(2):90–8.

    Article  PubMed  Google Scholar 

  32. Vega A, Martín-ferrero MA, Del Canto F, Alberca M, García V, Munar A, Orozco L, Soler R, Fuentes JJ, Huguet M, Sánchez A, García-Sancho J. Treatment of knee osteoarthritis with allogeneic bone marrow mesenchymal stem cells: a randomized controlled trial. Transplantation. 2015;99:1681–90.

    Article  CAS  PubMed  Google Scholar 

  33. Jobanputra P, Corrigall V, Kingsley G, Panayi G. Cellular responses to human chondrocytes: absence of allogeneic responses in the presence of HLA-DR and ICAM-1. Clin Exp Immunol. 1992;90:336–44.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  34. Romaniuk A, Malejczyk J, Kubicka U, Hyc A, Olszewski WL, Moskalewski S. Rejection of cartilage formed by transplanted allogeneic chondrocytes: evaluation with monoclonal antibodies. Transpl Immunol. 1995;3:251–7.

    Article  CAS  PubMed  Google Scholar 

  35. Adkisson HD, Martin JA, Amendola RL, Milliman C, Mauch KA, Katwal AB, Seyedin M, Amendola A, Streeter PR, Buckwalter JA. The potential of human allogeneic juvenile chondrocytes for restoration of articular cartilage. Am J Sports Med. 2010;38:1324–33.

    Article  PubMed Central  PubMed  Google Scholar 

  36. Acosta FL Jr, Metz L, Adkisson HD, Liu J, Carruthers-Liebenberg E, Milliman C, Maloney M, Lotz JC. Porcine intervertebral disc repair using allogeneic juvenile articular chondrocytes or mesenchymal stem cells. Tissue Eng Part A. 2011;17:3045–55.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  37. Ksiazek T, Moskalewski S. Studies on bone formation by cartilage reconstructed by isolated epiphyseal chondrocytes, transplanted synergeneically or across known histocompatibility barriers in mice. Clin Orthop Relat Res. 1983;172:233–42.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Daniel A. Grande.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Smith, B., Sigal, I.R. & Grande, D.A. Immunology and cartilage regeneration. Immunol Res 63, 181–186 (2015). https://doi.org/10.1007/s12026-015-8720-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12026-015-8720-7

Keywords

Navigation